Where Will Recursion Pharmaceuticals Be in 5 Years?

If it can bounce back and generate solid returns in the next five years, now is about as good a time as any to invest in the ...
Zacks Investment Research on MSN

Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains?

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Jim Cramer on Recursion: “I Need to See a Proof of Concept Here”

I don’t know. It’s been such a dog. It’s been a dog, we had them on, twice the price. It’s done absolutely nothing. I need to ...